Townes-Brocks syndrome
General Information (adopted from Orphanet):
Synonyms, Signs: |
DEAFNESS, SENSORINEURAL, WITH IMPERFORATE ANUS AND THUMB ANOMALIES TOWNES-BROCKS-BRANCHIOOTORENAL-LIKE SYNDROME, INCLUDED ANUS, IMPERFORATE, WITH HAND, FOOT, AND EAR ANOMALIES TBS Townes syndrome Sensorineural deafness with imperforate anus and hypoplastic thumbs renal-ear-anal-radial syndrome Imperforate anus with hand, foot and ear anomalies rear syndrome |
Number of Symptoms | 108 |
OrphanetNr: | 857 |
OMIM Id: |
107480
|
ICD-10: |
Q87.8 |
UMLs: |
|
MeSH: |
C536974 |
MedDRA: |
|
Snomed: |
|
Prevalence, inheritance and age of onset:
Prevalence: | 0.4 of 100 000 [Orphanet] |
Inheritance: |
Autosomal dominant [Orphanet] |
Age of onset: |
All ages [Orphanet] |
Disease classification (adopted from Orphanet):
Parent Diseases: |
Branchial arch or oral-acral syndrome
-Rare developmental defect during embryogenesis Genetic branchial arch or oral-acral syndrome -Rare genetic disease Genetic multiple congenital anomalies/dysmorphic syndrome without intellectual deficit -Rare genetic disease Multiple congenital anomalies/dysmorphic syndrome without intellectual deficit -Rare developmental defect during embryogenesis Otomandibular dysplasia associated with monogenic syndromes -Rare developmental defect during embryogenesis -Rare genetic disease -Rare maxillo-facial surgical disease -Rare otorhinolaryngologic disease Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy -Rare bone disease -Rare developmental defect during embryogenesis Syndromic anorectal malformation -Rare abdominal surgical disease -Rare developmental defect during embryogenesis -Rare genetic disease Syndromic genetic deafness -Rare developmental defect during embryogenesis -Rare genetic disease -Rare otorhinolaryngologic disease Syndromic renal or urinary tract malformation -Rare developmental defect during embryogenesis -Rare genetic disease -Rare renal disease |
Symptom Information:
|
(HPO:0000130) | Abnormality of the uterus | Occasional [Orphanet] | 86 / 7739 | |||
|
(HPO:0000047) | Hypospadias | Occasional [Orphanet] | 250 / 7739 | |||
|
(HPO:0010957) | Congenital posterior urethral valve | 9 / 7739 | ||||
|
(HPO:0000110) | Renal dysplasia | 7.5000 % [HPO] | 44 / 7739 | |||
|
(HPO:0000142) | Abnormality of the vagina | Occasional [Orphanet] | 24 / 7739 | |||
|
(HPO:0000003) | Multicystic kidney dysplasia | 7.5000 % [HPO] | 17 / 7739 | |||
|
(HPO:0000048) | Bifid scrotum | Occasional [Orphanet] | 36 / 7739 | |||
|
(HPO:0000076) | Vesicoureteral reflux | Occasional [Orphanet] 7.5000 % [HPO] | 94 / 7739 | |||
|
(HPO:0100542) | Abnormal localization of kidney | Occasional [Orphanet] | 64 / 7739 | |||
|
(HPO:0000083) | Renal insufficiency | Frequent [Orphanet] 7.5000 % [HPO] | 232 / 7739 | |||
|
(HPO:0000089) | Renal hypoplasia | 7.5000 % [HPO] | 78 / 7739 | |||
|
(HPO:0000136) | Bifid uterus | 6 / 7739 | ||||
|
(HPO:0000054) | Micropenis | Occasional [Orphanet] | 257 / 7739 | |||
|
(HPO:0010481) | Urethral valve | 7 / 7739 | ||||
|
(HPO:0004792) | Rectoperineal fistula | 3 / 7739 | ||||
|
(HPO:0000035) | Abnormality of the testis | Frequent [Orphanet] | 296 / 7739 | |||
|
(HPO:0000028) | Cryptorchidism | 347 / 7739 | ||||
|
(HPO:0000795) | Abnormality of the urethra | Occasional [Orphanet] | 38 / 7739 | |||
|
(HPO:0000143) | Rectovaginal fistula | 18 / 7739 | ||||
|
(HPO:0011331) | Hemifacial atrophy | Occasional [Orphanet] | 79 / 7739 | |||
|
(HPO:0000252) | Microcephaly | 832 / 7739 | ||||
|
(HPO:0000154) | Wide mouth | Occasional [Orphanet] | 137 / 7739 | |||
|
(HPO:0000581) | Blepharophimosis | Occasional [Orphanet] | 197 / 7739 | |||
|
(HPO:0000518) | Cataract | Occasional [Orphanet] | 454 / 7739 | |||
|
(HPO:0001140) | Epibulbar dermoid | Occasional [Orphanet] | 11 / 7739 | |||
|
(HPO:0000611) | Choroid coloboma | 12 / 7739 | ||||
|
(HPO:0000572) | Visual loss | Occasional [Orphanet] | 272 / 7739 | |||
|
(HPO:0000479) | Abnormality of the retina | Occasional [Orphanet] | 74 / 7739 | |||
|
(HPO:0000612) | Iris coloboma | Occasional [Orphanet] | 116 / 7739 | |||
|
(HPO:0000480) | Retinal coloboma | 16 / 7739 | ||||
|
(HPO:0000567) | Chorioretinal coloboma | 26 / 7739 | ||||
|
(HPO:0000486) | Strabismus | Occasional [Orphanet] | 576 / 7739 | |||
|
(HPO:0009921) | Duane anomaly | rare [HPO:skoehler] | 9 / 7739 | |||
|
(HPO:0008056) | Aplasia/Hypoplasia affecting the eye | Occasional [Orphanet] | 142 / 7739 | |||
|
(HPO:0008527) | Congenital sensorineural hearing impairment | 165 / 7739 | ||||
|
(HPO:0000356) | Abnormality of the outer ear | Very frequent [Orphanet] | 85 / 7739 | |||
|
(HPO:0000400) | Macrotia | 108 / 7739 | ||||
|
(HPO:0000407) | Sensorineural hearing impairment | 50.0000 % [HPO] | 524 / 7739 | |||
|
(HPO:0100015) | Stahl ear | 2 / 7739 | ||||
|
(HPO:0009912) | Abnormality of the tragus | Occasional [Orphanet] | 12 / 7739 | |||
|
(HPO:0004453) | Overfolding of the superior helices | 5 / 7739 | ||||
|
(HPO:0008772) | Aplasia/Hypoplasia of the external ear | Frequent [Orphanet] | 67 / 7739 | |||
|
(HPO:0000365) | Hearing impairment | Frequent [Orphanet] | 539 / 7739 | |||
|
(HPO:0008625) | Severe sensorineural hearing impairment | 150 / 7739 | ||||
|
(HPO:0000384) | Preauricular skin tag | Very frequent [Orphanet] 50.0000 % [HPO] | 62 / 7739 | |||
|
(HPO:0004467) | Preauricular pit | 50.0000 % [HPO] | 39 / 7739 | |||
|
(HPO:0008551) | Microtia | 50.0000 % [HPO] | 98 / 7739 | |||
|
(HPO:0001249) | Intellectual disability | 1089 / 7739 | ||||
|
(HPO:0006824) | Cranial nerve paralysis | Occasional [Orphanet] | 81 / 7739 | |||
|
(HPO:0000821) | Hypothyroidism | Occasional [Orphanet] | 141 / 7739 | |||
|
(HPO:0008191) | Thyroid agenesis | 11 / 7739 | ||||
|
(HPO:0008373) | Puberty and gonadal disorders | Occasional [Orphanet] | 156 / 7739 | |||
|
(HPO:0011304) | Broad thumb | 39 / 7739 | ||||
|
(HPO:0009465) | Ulnar deviation of finger | Occasional [Orphanet] | 48 / 7739 | |||
|
(HPO:0004209) | Clinodactyly of the 5th finger | Frequent [Orphanet] | 288 / 7739 | |||
|
(HPO:0010709) | 2-4 finger syndactyly | 7.5000 % [HPO] | 2 / 7739 | |||
|
(HPO:0010760) | Absent toe | Occasional [Orphanet] | 15 / 7739 | |||
|
(HPO:0001864) | Clinodactyly of the 5th toe | 50.0000 % [HPO] | 6 / 7739 | |||
|
(HPO:0001177) | Preaxial hand polydactyly | Very frequent [Orphanet] | 59 / 7739 | |||
|
(HPO:0001836) | Camptodactyly of toe | Frequent [Orphanet] | 27 / 7739 | |||
|
(HPO:0010055) | Broad hallux | Occasional [Orphanet] | 56 / 7739 | |||
|
(HPO:0001770) | Toe syndactyly | Occasional [Orphanet] | 149 / 7739 | |||
|
(HPO:0010743) | Short metatarsal | 56 / 7739 | ||||
|
(HPO:0009779) | 3-4 toe syndactyly | 4 / 7739 | ||||
|
(HPO:0100258) | Preaxial polydactyly | 39 / 7739 | ||||
|
(HPO:0006179) | Pseudoepiphyses of second metacarpal | 1 / 7739 | ||||
|
(HPO:0001172) | Abnormality of the thumb | Occasional [Orphanet] | 103 / 7739 | |||
|
(HPO:0009944) | Partial duplication of thumb phalanx | 7 / 7739 | ||||
|
(HPO:0001763) | Pes planus | Frequent [Orphanet] | 176 / 7739 | |||
|
(HPO:0000772) | Abnormality of the ribs | Occasional [Orphanet] | 146 / 7739 | |||
|
(HPO:0004691) | 2-3 toe syndactyly | 50 / 7739 | ||||
|
(HPO:0100559) | Lower limb asymmetry | Occasional [Orphanet] | 30 / 7739 | |||
|
(HPO:0001440) | Metatarsal synostosis | 4 / 7739 | ||||
|
(HPO:0003468) | Abnormality of the vertebrae | Occasional [Orphanet] | 77 / 7739 | |||
|
(HPO:0006097) | 3-4 finger syndactyly | 7 / 7739 | ||||
|
(HPO:0001760) | Abnormality of the foot | Frequent [Orphanet] | 96 / 7739 | |||
|
(HPO:0010331) | Aplasia/Hypoplasia of the 3rd toe | 1 / 7739 | ||||
|
(HPO:0002025) | Anal stenosis | 23 / 7739 | ||||
|
(HPO:0002247) | Duodenal atresia | 13 / 7739 | ||||
|
(HPO:0002019) | Constipation | Frequent [Orphanet] | 194 / 7739 | |||
|
(HPO:0001545) | Anteriorly placed anus | Frequent [Orphanet] | 55 / 7739 | |||
|
(HPO:0002020) | Gastroesophageal reflux | 101 / 7739 | ||||
|
(HPO:0002023) | Anal atresia | Very frequent [Orphanet] 46.9697 % [HPO] | 135 / 7739 | |||
|
(HPO:0004378) | Abnormality of the anus | Very frequent [Orphanet] | 34 / 7739 | |||
|
(HPO:0002607) | Bowel incontinence | Occasional [Orphanet] | 33 / 7739 | |||
|
(HPO:0001537) | Umbilical hernia | 206 / 7739 | ||||
|
(HPO:0004322) | Short stature | Occasional [Orphanet] | 1232 / 7739 | |||
|
(HPO:0004325) | Decreased body weight | Occasional [Orphanet] | 492 / 7739 | |||
|
(HPO:0001031) | Subcutaneous lipoma | Frequent [Orphanet] | 112 / 7739 | |||
|
(HPO:0004760) | Congenital septal defect | Occasional [Orphanet] | 69 / 7739 | |||
|
(HPO:0030680) | Abnormality of cardiovascular system morphology | Occasional [Orphanet] | 355 / 7739 | |||
|
(HPO:0001641) | Abnormality of the pulmonary valve | Occasional [Orphanet] | 27 / 7739 | |||
|
(HPO:0001643) | Patent ductus arteriosus | Occasional [Orphanet] | 228 / 7739 | |||
|
(HPO:0001636) | Tetralogy of Fallot | Occasional [Orphanet] | 104 / 7739 | |||
|
(HPO:0001629) | Ventricular septal defect | 316 / 7739 | ||||
|
(HPO:0001631) | Atria septal defect | Occasional [Orphanet] | 274 / 7739 | |||
|
(HPO:0001199) | Triphalangeal thumb | Very frequent [Orphanet] 50.0000 % [HPO] | 56 / 7739 | |||
|
(OMIM) | Fusion of triquetrum and hamate | 1 / 7739 | ||||
|
(HPO:0007370) | Aplasia/Hypoplasia of the corpus callosum | Occasional [Orphanet] | 180 / 7739 | |||
|
(OMIM) | 2-3 and 3-4 finger syndactyly | 1 / 7739 | ||||
|
(OMIM) | Rectovaginal/rectoperineal fistula | 1 / 7739 | ||||
|
(HPO:0000006) | Autosomal dominant inheritance | 2518 / 7739 | ||||
|
(OMIM) | [DEL]Vaginal aplasia | 1 / 7739 | ||||
|
(OMIM) | Anterior placement of anus | 1 / 7739 | ||||
|
(OMIM) | Absent triquetrum and navicular bones | 1 / 7739 | ||||
|
(HPO:0002308) | Arnold-Chiari malformation | Occasional [Orphanet] | 42 / 7739 | |||
|
(HPO:0012758) | Neurodevelopmental delay | Occasional [Orphanet] | 949 / 7739 | |||
|
(OMIM) | Prominent midline perineal raphe | 1 / 7739 |
Associated genes:
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|
Additional Information:
Clinical Description OMIM |
Townes and Brocks (1972) observed a father and 5 of his 7 children who had imperforate anus, triphalangeal thumbs, and other anomalies of the hands and feet, including fusion of metatarsals, absent bones, and supernumerary thumbs. Other features ... |
Genotype-Phenotype Correlations OMIM |
Furniss et al. (2007) reported a heterozygous mutation in the SALL1 gene (995delC; 602218.0011) in a patient with a relatively severe form of Townes-Brocks syndrome. The patient had bilateral preaxial polydactyly, imperforate anus, rectal atresia, hypospadias, and overfolded ... |
Molecular genetics OMIM |
In 2 half-sibs with TBS, born of the same mother, and a sporadic TBS patient, Kohlhase et al. (1998) identified 2 different heterozygous mutations in the SALL1 gene (602218.0001; 602218.0002). In a father and 2 daughters ... |
Diagnosis GeneReviews | Townes-Brocks syndrome (TBS) is diagnosed clinically based on the presence of the following:... Gene SymbolTest MethodsMutations DetectedMutation Detection Frequency by Gene and Test Method 1Test AvailabilitySALL1Sequence analysis / mutation scanning | Sequence variants 2<70% Clinical Deletion / duplication analysis 3Exonic, multiexonic, or whole-gene deletions <5% 1. The ability of the test method used to detect a mutation that is present in the indicated gene2. Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations.3. Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.Interpretation of test results. For issues to consider in interpretation of sequence analysis results, click here.Testing Strategy To establish the diagnosis in a proband with typical thumb, anal, and ear malformations Perform cardiac evaluation, ophthalmologic examination, and renal ultrasound examination in addition to a routine physical examination. Check for renal impairment by routine laboratory tests even if the kidneys appear normal on ultrasound. Perform hand/forearm x-ray investigations to evaluate for involvement of the radius. If at least two out of three classic major TBS features (anal, ear, and typical thumb malformations) are found, SALL1 molecular genetic testing is suggested as the first step. Presence of additional minor features (i.e., those commonly observed in TBS) increases the likelihood of finding a SALL1 mutation. Atypical features (i.e., not yet reported to occur with SALL1 mutations) may decrease the SALL1 mutation detection rate, but currently it does not seem possible to determine which atypical features (with the exception of concomitant involvement of the radius) are true negative predictors of a SALL1 mutation. Molecular genetic testing of SALL4 rather than SALL1 is suggested as the first molecular test if the radius is involved and/or if Duane anomaly is present. In a few individuals, complete overlap exists between Okihiro syndrome and TBS [Kohlhase et al 2002; Borozdin et al 2004; Kohlhase, personal communication]. In those individuals, both SALL1 and SALL4 molecular genetic testing should be considered. See Differential Diagnosis, Okihiro syndrome and SALL4-Related Disorders.Predictive testing for at-risk asymptomatic adult family members requires prior identification of the disease-causing mutations in the family.Prenatal diagnosis and preimplantation genetic diagnosis (PGD) for at-risk pregnancies require prior identification of the disease-causing mutation in the family.Genetically Related (Allelic) DisordersNo other distinct phenotypes are known to be associated with SALL1 mutations.
Clinical Description GeneReviews | In addition to the clinical features described in Diagnosis, the clinical manifestations of Townes-Brocks Syndrome may include the following:... |
Genotype-Phenotype Correlations GeneReviews | No genotype-phenotype correlations have been made for the majority of mutations, most of which are private.... |
Differential Diagnosis GeneReviews | No other distinct phenotypes are associated with SALL1 mutations, but the clinical presentation of Townes-Brocks syndrome (TBS) can overlap with Goldenhar syndrome (hemifacial microsomia) [Gabrielli et al 1993, Kohlhase et al 1999, Keegan et al 2001], Okihiro syndrome (but without malformations of the radius) [Borozdin et al 2004], and branchiootorenal syndrome [Engels et al 2000, Albrecht et al 2004]. TBS also overlaps with VACTERL association.... |
Management GeneReviews | To establish the extent of disease in an individual diagnosed with Townes-Brocks syndrome (TBS), the following evaluations are recommended:... |
Molecular genetics GeneReviews |
Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. —ED.... Gene SymbolChromosomal LocusProtein NameLocus SpecificHGMDSALL116q12 | Sal-like protein 1SALL1 homepage - Mendelian genesSALL1Data are compiled from the following standard references: gene symbol from HGNC; chromosomal locus, locus name, critical region, complementation group from OMIM; protein name from UniProt. For a description of databases (Locus Specific, HGMD) to which links are provided, click here.Table B. OMIM Entries for Townes-Brocks Syndrome (View All in OMIM) View in own window 107480TOWNES-BROCKS SYNDROME; TBS 602218SAL-LIKE 1; SALL1Normal allelic variants. SALL1 occupies about 14.1 kb (start codon to stop codon). It contains three exons (all coding) and two introns. The genomic sequence is available at www.ncbi.nlm.nih.gov (accession number NC_000016.8); 29 different non-pathogenic polymorphisms are currently known [Bohm et al 2006]. Pathologic allelic variants. All reported and confirmed mutations are truncating and positioned in exon 2 and intron 2 of the gene [Kohlhase et al 1998, Kohlhase et al 1999, Marlin et al 1999, Blanck et al 2000, Engels et al 2000, Kohlhase 2000, Salerno et al 2000, Surka et al 2001, Devriendt et al 2002, Kohlhase et al 2003, Walter et al 2006]. Forty-six out of the 56 known SALL1 mutations are located between the coding regions for the glutamine-rich domain mediating SALL protein interactions and 65 bp 3' of the coding region for the first double zinc finger domain, narrowing the SALL1 mutational hotspot region to a stretch of 802 bp within exon 2. Based on studies in mouse and chicken [Kiefer et al 2003, Sweetman et al 2003], it seems likely that the mutations escape nonsense-mediated messenger decay and therefore do not result in haploinsufficiency of the protein encoded by SALL1. However, three families in whom larger deletions partially or completely removing SALL1 clearly result in TBS have been described [Borozdin et al 2006]. One family had a heterozygous deletion of all exons, one had deletion of the entire SALL1 gene and several neighboring genes, and one had deletion of intron 2 and partial deletion of exons 2 and 3. These findings confirm that SALL1 haploinsufficiency can cause the phenotype, but it appears that the phenotype associated with larger deletions is at least milder than that of c.826C>T (though not milder than the phenotype associated with several other point mutations).Normal gene product. SALL1 encodes a C2H2 zinc finger protein of the SAL type, similar to the SAL protein encoded by the Drosophila gene spalt. It contains four double zinc finger domains characteristically distributed over the protein. There are also two single zinc fingers, a C2HC domain at the N terminus and a C2H2 finger attached to the second double zinc finger. SALL1 is found strictly in the cell nucleus; it binds to heterochromatic foci and contains repressor domains at the N-terminus and in the central region [Netzer et al 2001, Netzer et al 2006]. Expression of csal1 (the chick orthologue of SALL1) in the limb is activated by ectopic SHH. However, this activation requires signals from the apical ectodermal ridge and involves FGF4/8 as well as Wnt3a and Wnt7a [Farrell & Munsterberg 2000], showing that csal1 expression is under control of at least three different pathways. In zebrafish, the SALL1 homologue sall1a is regulated by tbx5 and required for fgf10 and fgfr2 expression in the posterior pectoral fin bud [Harvey & Logan 2006]. In the mouse, Sall1 was found to enhance the canonical Wnt signaling pathway by localizing to pericentromeric heterochromatin [Sato et al 2004]. Abnormal gene product. All SALL1 mutations (except for the larger deletions) detected in persons with TBS to date result in premature stop codons. Since transcripts with a premature stop codon are in most instances rapidly degraded, these mutations are a priori likely to cause TBS via SALL1 haploinsufficiency [Hentze & Kulozik 1999, Maquat 2004]. Proof for SALL1 haploinsufficiency being involved in the pathogenesis of human TBS came from the recent detection of a heterozygous 75-kb deletion of the entire SALL1 coding region in a family with TBS [Borozdin et al 2006]. However, the Sall1 knock-out mouse showed that loss of Sall1 function does not result in defects that affect tissues other than kidney [Nishinakamura et al 2001]. Introducing a TBS mutation in mouse Sall1 instead leads to a TBS-like phenotype, and the detection of truncated Sall1 proteins points to a role of those proteins in the pathogenesis of TBS [Kiefer et al 2003]. In the zebrafish, sall1a loss of function leads to defective limb development, which can be aggravated by concomitant knock-down of sall4 [Harvey & Logan 2006].Comparison of the phenotypes associated with a SALL1 deletion or with the severe p.Arg276X mutation indicate that the malformations in the family with the 75-kb deletion were relatively mild [Borozdin et al 2006]. It could therefore be that SALL1 deletions (i.e., SALL1 haploinsufficiency) cause milder phenotypes than truncating mutations. This would require that mutated SALL1 transcripts with premature stop codons escape the NMD pathway and lead to truncated proteins similar to those detected in mice with a TBS-causing mutation. However, truncated SALL1 proteins have not been found in lymphoblastoid and amniotic fluid cells of persons with TBS [Kohlhase & Rauchman, unpublished data], possibly because tissues most strongly expressing SALL1 in the adult (brain and kidney) have not been accessible for investigation.Csal (chicken) and Sall (mouse) proteins can interact with each other via mediation of an N-terminal glutamine-rich domain conserved in all known Sal proteins. Expression of truncated Sall1/ csal1 proteins is detected throughout the cell and not confined to the nucleus as full-length Sall1. Truncated Sall1 can interact with full-length Sall proteins and cause their displacement from the nucleus [Kiefer et al 2003, Sweetman et al 2003].Alleles resulting from SALL1 mutations in the 5' region of exon 2 encode for truncated proteins with strong repressor activity but without the central repression and heterochromatin localization domain [Netzer et al 2006]. Despite their potential to act as strong transcriptional repressors, these proteins will probably not localize to the physiologic site of action, but bind other SAL proteins and move them from the nucleus to the cytoplasm. Mutations further 3' in SALL1 likely result in milder phenotypes than the 5' mutations [Blanck et al 2000, Botzenhart et al 2005]. If some of those mutations lead to truncated proteins including both repression domains and the heterochromatin localization domain, these proteins could still localize to their place of action and have some residual function, which could explain the milder phenotype.The critical point in the pathogenesis seems to be the correct dosage of functional SALL1 protein at the heterochromatic foci. A deletion of one allele results in a 50% reduction of this dosage. A 5' truncating mutation possibly leads to a truncated protein, which does not reach its site of action and in addition probably even removes some full-length protein of the normal allele from the nucleus. Therefore, in most instances the more severe phenotype of the 5' truncating mutations may result from a greater than 50% reduction of the functional protein at the site of action.The additive phenotype of the combined sall4 and sall1a knock-down in zebrafish suggests that both genes may be able to compensate to some extent for each other. In view of the additive effects of sall1a and sall4 knock-down on limb development it remains unclear if the TBS phenotype in humans is only caused by loss of SALL1 function or also by an effect of the hypothetical truncated SALL1 proteins on the function of other SALL proteins.As the interaction between truncated SALL1 and functional SALL1 or other SALL proteins and the relocalization of the functional proteins requires the presence of the evolutionarily conserved glutamine-rich region in the amino-terminal part of the truncated protein, the effect of the TBS-causing SALL1 mutations c.419delC and c.313delA, which would result in truncated proteins lacking the interaction domain, still needs to be explained, since the phenotypes associated with these mutations did not appear milder than the phenotypes resulting from other mutations [Kohlhase et al 1999, Botzenhart et al 2007].Interestingly, 47 of 57 (82.5%) smaller mutations cluster within the 802-bp refined "hot spot region" between the coding sequence for the glutamine-rich domain and the coding sequence for the first double zinc finger, whereas only two mutations were found within the remaining 763 bp upstream in the coding region, and only six within the 2.4-kb coding region to the 3' end. Therefore, the existence of truncated proteins in cells of persons with TBS would not be surprising. If it holds true that SALL1 point mutations lead to truncated SALL1 proteins with dominant-negative action, one could expect that all truncated proteins have at least slightly different characteristics. This could explain the considerable phenotypic variability observed in TBS.